nacfc 2022 | s21: preclinical assessment of novel genetic therapies
Published 1 year ago • 333 plays • Length 1:59:13Download video MP4
Download video MP3
Similar videos
-
1:52:31
nacfc 2022 | s01: design of clinical trials to evaluate nucleotide-based interventions
-
1:33:55
nacfc 2022 | w21: evidence-based medicine: update on clinical trials in cystic fibrosis
-
1:02:36
cf foundation | nacfc 2022 highlights
-
2:00:17
nacfc 2021 | s21: biomarkers & trial designs for novel cystic fibrosis therapies
-
1:40:01
nacfc 2022 | s20: best pt/rt practices in palliative care
-
1:57:14
nacfc 2022 | w36: genetic and cell-based approaches to cystic fibrosis therapy
-
16:50
what is gene editing? how does crispr/cas9 modify dna? li yongle talks about genetic engineering(1)
-
1:00:24
cf foundation | research overview: path to a cure
-
2:31
cystic fibrosis mechanism and treatment | hhmi biointeractive video
-
59:57
cf foundation | research overview: genetic therapies in cystic fibrosis
-
3:55
nacfc 2020: how genetic-based therapies could restore cftr function
-
1:28:57
nacfc 2022 | l&l04: making sense out of cftr genotyping reports: legacies, stars, and symbols
-
17:52
cf foundation | cf genetic counseling beyond 1 in 4
-
2:02:57
nacfc 2022 | dg08: genetics and genetic counseling
-
2:00:46
nacfc 2022 | s24: role of cftr during epithelial development, differentiation, and regeneration
-
3:06
novel therapy for cystic fibrosis completes phase 2 trial
-
15:40
cystic fibrosis center outcomes with new modulator therapies
-
57:37
cf foundation | genetics basics and an introduction to genetic therapies for cf
-
2:00:19
nacfc 2022 | s13: progress towards genomic correction of cystic fibrosis lung disease
-
1:17:30
nacfc 2020 | s21: cftr: biology boosting cftr expression and function